ENDRA Life Sciences reports ASP Isotopes as 10% owner
LHE LNG’s $6.57 warrants require stockholder approval before exercise and expire May 27, 2031; part of its pre-funded warrant position also requires approval.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
ENDRA Life Sciences Inc. (NDRA) reports ASP Isotopes Inc. and LHE LNG Holdings LLC as 10% owners, with securities held by LHE LNG: 66,846 common shares, pre-funded warrants covering 511,541 common shares, and warrants covering 1,156,774 common shares. The pre-funded warrants have a $0.0001 exercise price; the warrants have a $6.57 exercise price. ASP Isotopes controls LHE LNG, and each entity disclaims beneficial ownership except to the extent of its respective pecuniary interest.
Insights
Analyzing...
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
ASP Isotopes Inc., LHE LNG Holdings LLC
Role
10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Pre-Funded Warrants F3, F2 | -- | -- | -- |
| holding | Warrants F4, F2 | -- | -- | -- |
| holding | Common Stock F1, F2 | -- | -- | -- |
Holdings After Transaction:
Pre-Funded Warrants — 511,541 contracts (Indirect, By LHE LNG Holdings LLC);
Warrants — 1,156,774 contracts (Indirect, By LHE LNG Holdings LLC);
Common Stock — 66,846 shares (Indirect, By LHE LNG Holdings LLC)
Footnotes (4)
- F1. Represents 66,846 shares of common stock, par value $0.0001 per share (the "Common Stock"), of ENDRA Life Sciences Inc. (the "Issuer"), held by LHE LNG Holdings LLC ("LHE LNG"), a wholly owned subsidiary of ASP Isotopes Inc. (the "ASP Isotopes").
- F2. Represents securities held by LHE LNG. ASP Isotopes controls LHE LNG and may be deemed to beneficially own securities of the Issuer held by LHE LNG. ASP Isotopes and LHE LNG each disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. This report shall not be deemed an admission that ASP Isotopes or LHE LNG is the beneficial owner of such securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F3. Represents pre-funded warrants to purchase up to (i) 187,169 shares of Common Stock of the Issuer held by LHE LNG exercisable within 60 days of the date hereof and (ii) 324,372 shares of Common Stock of the Issuer held by LHE LNG exercisable on or after the date that the Issuer obtains stockholder approval of the issuance of the shares of Common Stock underlying the pre-funded warrants and warrants reported herein (the "Stockholder Approval"). The pre-funded warrants do not expire.
- F4. Represents warrants to purchase an aggregate of up to 1,156,774 shares of Common Stock at an exercise price of $6.57 held by LHE LNG, which are not exercisable until Stockholder Approval is obtained. The warrants expire on May 27, 2031.
Key Figures
Common shares held: 66,846 shares
Pre-funded warrant underlying shares: 511,541 shares
Pre-funded warrant exercise price: $0.0001 per share
+4 more
7 metrics
Common shares held
66,846 shares
Held by LHE LNG Holdings LLC
Pre-funded warrant underlying shares
511,541 shares
Underlying common shares held by LHE LNG Holdings LLC
Pre-funded warrant exercise price
$0.0001 per share
Pre-funded warrants held by LHE LNG Holdings LLC
Pre-funded warrant shares exercisable within 60 days
187,169 shares
As stated in the warrant footnote
Pre-funded warrant shares subject to stockholder approval
324,372 shares
Exercisable on or after stockholder approval
Warrant underlying shares
1,156,774 shares
Underlying common shares held by LHE LNG Holdings LLC
Warrant exercise price
$6.57 per share
Warrants held by LHE LNG Holdings LLC
Key Terms
Pre-Funded Warrants, pecuniary interest, Stockholder Approval, beneficial ownership
4 terms
Pre-Funded Warrants technical
"Pre-Funded Warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
pecuniary interest regulatory
"except to the extent of their respective pecuniary interest therein"
Stockholder Approval regulatory
"the "Stockholder Approval""
Stockholder approval is formal consent given by a company’s shareholders, usually through a vote at a meeting or by proxy, for major actions such as mergers, asset sales, changes to corporate structure, or amendments to governance rules. Investors pay attention because the vote can enable or block steps that materially change a company’s direction, ownership or value—like neighbors voting to allow a major renovation that would alter a building’s use and worth.
beneficial ownership regulatory
"disclaims beneficial ownership of such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the NDRA warrant exercise terms?
The pre-funded warrants cover 511,541 common shares at $0.0001 per share and do not expire; 187,169 shares are exercisable within 60 days, while 324,372 are exercisable on or after stockholder approval. Separate warrants cover 1,156,774 shares at $6.57 per share, are exercisable only after approval, and expire May 27, 2031.
AI-generated analysis. How Rhea-AI works. Not financial advice.
